cyclocreatine has been researched along with Experimental Neoplasms in 2 studies
cyclocreatine: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lillie, JW | 1 |
| O'Keefe, M | 1 |
| Valinski, H | 1 |
| Hamlin, HA | 1 |
| Varban, ML | 1 |
| Kaddurah-Daouk, R | 2 |
| Bergnes, G | 1 |
| Yuan, W | 1 |
| Khandekar, VS | 1 |
| O'Keefe, MM | 1 |
| Martin, KJ | 1 |
| Teicher, BA | 1 |
2 other studies available for cyclocreatine and Experimental Neoplasms
| Article | Year |
|---|---|
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine | 1993 |
Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Death; Colonic Neo | 1996 |